• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22345 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2002     Basque Office for Health Technology Assessment (OSTEBA) [Tumour markers in certain cancer locations]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 1 diabetes]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Methodological project: Synthesis of information in support of multicriteria decision analysis (MCDA) for decision making]
2012     Basque Office for Health Technology Assessment (OSTEBA) [They just told me I have diabetes! Guide for youth and adults with type 1 diabetes and in intensive treatment]
2018     Basque Office for Health Technology Assessment (OSTEBA) [HIFU —High intensity focused ultrasound— in essential tremor]
2005     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on asthma]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the scientific evidence on nipple-areola complex micropigmentation, requirements for its proper implementation and costs]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guideline on Childhood Asthma]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Immunological faecal occult blood test for patients with symptoms compatible with colorectal cancer: recommendation of Clinical Practice Guides and use in the National Health System]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Radiofrequency tonsil reduction]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Evidence-based recommendations for vascular access care]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Effectiveness and safety of bone suppression technology for the detection of lung cancer and indications for its use]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Evidence-based recommendations for fall prevention]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Strategies for promoting and strengthening evidence-based nursing in the Basque Country]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Guide to evidence-based recommendations in the prevention and treatment of pressure ulcers in adults]
2018     Basque Office for Health Technology Assessment (OSTEBA) [Checklist for ethical and legal domains analysis]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Guide on Prader-Willi Syndrome. Guide to health personnel for the adequate knowledge and management of a rare disease called Prader-Willi Syndrome]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Effectiveness of non-invasive mechanical ventilation for the treatment of respiratory failure in patients with amyotrophic lateral sclerosis]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Online hemodiafiltration: evaluation of its safety, effectiveness, cost and usage indications]
2017     Basque Office for Health Technology Assessment (OSTEBA) [ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (EMD) in superficial gastrointestinal tumors]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the efficacy, safety and efficiency of stabilisation of intervertebral discs using Discogel]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical effectiveness and cost-effectiveness of non-invasive telemonitoring on patients with heart failure]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2017     Basque Office for Health Technology Assessment (OSTEBA) [System for percutaneous replacement of mitral valve (MitraClip). Monitoring Study Protocol (1st part)]
2017     Basque Office for Health Technology Assessment (OSTEBA) [System for percutaneous replacement of mitral valve using a Clip. Monitoring study (part 2)]
2001     Basque Office for Health Technology Assessment (OSTEBA) [Last trends in genetic therapy]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Design and validation of a screening tool for evaluating the health impact of regional policies]
2008     Basque Office for Health Technology Assessment (OSTEBA) [State-wide network of identification, prioritization and early assessment of new and emerging health technologies]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Report on the development of the GuNFT guideline. Guideline for not funding existing health technologies in health care systems]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of care times for the main cancer sites: colon/rectum, lung, breast and prostate]
2000     Basque Office for Health Technology Assessment (OSTEBA) [New imaging techniques for diagnosis of breast cancer: digital mammography, impedance and electrical conductivity]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of healthcare status and therapeutic recommendations concerning attention deficit hyperactivity disorder]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Impact of the implementation of EFQM in Osakidetza]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Auditive implants: concept, indications and appropriate use]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Prevention of Type 2 Diabetes Mellitus in Primary Health Care through healthy lifestyles: care and recommended clinical interventions]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Human assisted reproductive techniques: Description of the available therapeutic options]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of factors related to the pharmaceutical expenditure in Primary Care, and prescription quality in chronic diseases]
2001     Basque Office for Health Technology Assessment (OSTEBA) [Sperm washing in HIV assisted fertilization]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Impact of the implementation of a population-based cervical cancer screening program based on European recommendations (test/interval) with regard to the current situation]
2002     Basque Office for Health Technology Assessment (OSTEBA) [Hemodilution and perioperative blood recovery]
2016     Basque Office for Health Technology Assessment (OSTEBA) [An image-guided system for liver surgery (CAScination)]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Home health care of patients with terminal illnesses in the Basque Autonomous Community]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Economic analysis of peripherally inserted central venous catheters (PICC), inserted by nursing staff, in cancer and hematological patients]
2001     Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness analysis of treatments of sleep apnea syndrome in the Basque Country]
2003     Basque Office for Health Technology Assessment (OSTEBA) [Minimum characteristics of a cardiac rehabilitation programme in the Basque Autonomous Community]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Interventions to improve CPAP treatment adherence in patients with obstructive sleep apnea]
2003     Basque Office for Health Technology Assessment (OSTEBA) [The health, economic and social impact of low back pain in the Autonomous Community of the Basque Country]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Prenatal screening for Down syndrome through fetal DNA sequencing from maternal blood]
2005     Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the evolution of main causes of mortality in 65 and older people in the Basque Country (1986-2001)]
2020     Basque Office for Health Technology Assessment (OSTEBA) [Efficacy and safety of mechanical thrombectomy in the treatment of patients with ischaemic stroke beyond 6 hours after onset or with an unknown time of onset]
2005     Basque Office for Health Technology Assessment (OSTEBA) [Proposal for a programme for the early detection of infant deafness in the Basque Autonomous Community]
2020     Basque Office for Health Technology Assessment (OSTEBA) [Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2006     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of the effectiveness of the intraoperative detection of the sentry ganglion in solid tumours]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Geographical mental health map: geographical variation in psychosis and association with environmental factors]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Relationship between use of cannabis and other drugs and psychiatric pathology in adolescents. A proposal of inpatient and outpatient mental health care in the Basque Health Service]
2015     Basque Office for Health Technology Assessment (OSTEBA) [An evaluation of the efficacy of psychosocial techniques (cognitive rehabilitation vs. psychoeducation) as an additional treatment to pharmacological treatment in bipolar disorder]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of care quality in the national health service towards severe childhood mental disorders. A study in infant/juvenile mental health services]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Telemonitoring multi-pathological chronic patients with heart or lung disease. Evaluation of the implementation in Primary Care]
2022     Austrian Institute for Health Technology Assessment (AIHTA) ATMPs and gene therapies in development. Horizon scanning – update 2022
2021     Austrian Institute for Health Technology Assessment (AIHTA) Long COVID care pathways: a systematic review
2023     Austrian Institute for Health Technology Assessment (AIHTA) Image-guided spinal injections in the treatment of chronic spinal pain: an overview of evidence-based guideline recommendations and specific focus on guidance techniques
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Robot-assisted rehabilitation for incomplete spinal cord injury]
2023     Austrian Institute for Health Technology Assessment (AIHTA) SMA therapies: mid- to long-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec and ≥12 months for patients treated with risdiplam or combination therapies
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Strategies for recruitment and programme adherence in group programmes for children, adolescents and adults with overweight and grade 1 obesity]
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Myopia control spectacle lenses for children and adolescents]
2021     Austrian Institute for Health Technology Assessment (AIHTA) [Process and evaluation of digital health applications in the context of "symptom-checkers"]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Registries in Austria and their utilisation for healthcare improvement]
2021     Austrian Institute for Health Technology Assessment (AIHTA) National strategies and programmes for preventing and managing non-communicable diseases in selected countries
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Autologous fat grafting in osteoarthritis]
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Endovenous laser therapy for varicose veins in the lower extremities]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Upper airway stimulation for moderate-to-severe sleep apnoea. Update 2022
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2022     Austrian Institute for Health Technology Assessment (AIHTA) Subcutaneous implantable cardioverter-defibrillator (S-ICD). Update 2022
2022     Austrian Institute for Health Technology Assessment (AIHTA) CAR-T cell therapy: Contrasting the evidence from pivotal trials with the real world evidence (RWE)
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous transvascular implantation of a coronary sinus reducing stent. Update 2022
2022     Austrian Institute for Health Technology Assessment (AIHTA) Hepatic and portal vein embolisation prior to major hepatectomy
2020     Austrian Institute for Health Technology Assessment (AIHTA) Proton and carbon ion therapy - an update on indications
2022     Austrian Institute for Health Technology Assessment (AIHTA) Microwave ablation for liver tumours
2022     Austrian Institute for Health Technology Assessment (AIHTA) Osteopathy: effectiveness and safety for musculoskeletal pain and overview of training and quality requirements
2022     Austrian Institute for Health Technology Assessment (AIHTA) His-bundle-pacing for patients requiring a permanent pacemaker or cardiac resynchronisation
2022     Austrian Institute for Health Technology Assessment (AIHTA) Chemosaturation with percutaneous hepatic perfusion for patients with liver cancer
2022     Austrian Institute for Health Technology Assessment (AIHTA) Lower esophageal sphincter devices for laparoscopic surgery in patients with gastroesophageal reflux disease (GERD)
2022     Austrian Institute for Health Technology Assessment (AIHTA) Child and adolescent mental health care models: a scoping review
2022     Austrian Institute for Health Technology Assessment (AIHTA) [Risk-based breast cancer screening in Austria: a systematic analysis of predictive models to assess individual breast cancer risk, their utility and applicability in a breast cancer screening programme]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Quality registries in dementia care: mapping of registries to improve quality and service delivery
2023     Austrian Institute for Health Technology Assessment (AIHTA) Biomarkers in Alzheimer's disease
2023     Austrian Institute for Health Technology Assessment (AIHTA) Robot-assisted surgery in thoracic and visceral indications – Update 2023
2022     Austrian Institute for Health Technology Assessment (AIHTA) Perinatal and infant mental health care models and pathways
2021     Austrian Institute for Health Technology Assessment (AIHTA) The economic and societal dimension of parental mental illness. Part 1: systematic review. Part II: economic evaluation framework
2021     Austrian Institute for Health Technology Assessment (AIHTA) ≥ 12 month follow-up of patients with spinal muscular atrophy (SMA) treated with Spinraza®, Zolgensma® or combination therapies
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
2020     Austrian Institute for Health Technology Assessment (AIHTA) Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 1; Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 2 (Appendix)
2020     Austrian Institute for Health Technology Assessment (AIHTA) Home-Treatment in Child and Adolescent Psychiatry: An Analysis of the Effectiveness and Possible Implementation in Austria
2023     Austrian Institute for Health Technology Assessment (AIHTA) [IV immunoglobulins (IgVena) in recurrent in vitro fertilisation implantation failure and/or recurrent pregnancy loss]
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Extracorporeal shock wave therapy for orthopaedic indications]
2023     Austrian Institute for Health Technology Assessment (AIHTA) Perinatal and infant mental health care in Austria. A mapping of existing prevention, screening and care structures, with a specific focus on Tyrol